Literature DB >> 26377489

Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients.

Charles Chazot1, Ken Farrington2,3, Ionut Nistor4,5, Wim Van Biesen4,6, Hanneke Joosten7, Daniel Teta8, Dimitrie Siriopol5, Adrian Covic9.   

Abstract

In the last decade, an increasing number of patients over 75 years of age are starting renal replacement therapy. Frailty is highly prevalent in elderly patients with end-stage renal disease (ESRD) in the context of the increased prevalence of some ESRD-associated conditions: protein-energy wasting, inflammation, anaemia, acidosis or hormonal disturbances. There are currently no hard data to support guidance on the optimal duration of dialysis for frail/elderly ESRD patients. The current debate is not about starting dialysis or managing conservatory frail ESRD patients, but whether a more intensive regimen once dialysis is initiated (for whatever reasons and circumstances) would improve patients' outcome. The most important issue is that all studies performed with extended/alternative dialysis regimens do not specifically address this particular type of patients and therefore all the inferences are derived from the general ESRD population. Care planning should be responsive to end-of-life needs whatever the treatment modality. Care in this setting should focus on symptom control and quality of life rather than life extension. We conclude that, similar to the general dialysed population, extensive application of more intensive dialysis schedules is not based on solid evidence. However, after a thorough clinical evaluation, a limited period of a trial of intensive dialysis could be prescribed in more problematic patients.

Entities:  

Keywords:  Dialysis; Elderly; Frail

Mesh:

Year:  2015        PMID: 26377489     DOI: 10.1007/s11255-015-1107-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  82 in total

1.  Revised dialysis clinical practice guideline promotes more informed decision-making.

Authors:  Alvin H Moss
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

2.  Withdrawal from dialysis: a palliative care perspective.

Authors:  S Chater; S N Davison; M J Germain; L M Cohen
Journal:  Clin Nephrol       Date:  2006-11       Impact factor: 0.975

3.  Significance of frailty among dialysis patients.

Authors:  Kirsten L Johansen; Glenn M Chertow; Chengshi Jin; Nancy G Kutner
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

Review 4.  Daily hemodialysis: a systematic review.

Authors:  Rita S Suri; Gihad E Nesrallah; Rahul Mainra; Amit X Garg; Robert M Lindsay; Tom Greene; John T Daugirdas
Journal:  Clin J Am Soc Nephrol       Date:  2005-11-16       Impact factor: 8.237

5.  Palliative dialysis in end-stage renal disease.

Authors:  Disha D Trivedi
Journal:  Am J Hosp Palliat Care       Date:  2011-03-10       Impact factor: 2.500

6.  The Janus-faced aspect of 'dry weight'.

Authors:  C Chazot; B Charra; C Vo Van; G Jean; T Vanel; E Calemard; J C Terrat; M Ruffet; G Laurent
Journal:  Nephrol Dial Transplant       Date:  1999-01       Impact factor: 5.992

7.  Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.

Authors:  Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez
Journal:  Nephrol Dial Transplant       Date:  2013-12-08       Impact factor: 5.992

8.  Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.

Authors:  Minmin Zhang; Mengjing Wang; Haiming Li; Ping Yu; Li Yuan; Chuanming Hao; Jing Chen; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2014-08-23       Impact factor: 3.754

9.  A communication framework for dialysis decision-making for frail elderly patients.

Authors:  Jane O Schell; Robert A Cohen
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-26       Impact factor: 8.237

Review 10.  The elderly patient on dialysis: geriatric considerations.

Authors:  Pooja Singh; Michael J Germain; Lewis Cohen; Mark Unruh
Journal:  Nephrol Dial Transplant       Date:  2013-06-19       Impact factor: 5.992

View more
  5 in total

1.  Assisted Peritoneal Dialysis as an Alternative to In-Center Hemodialysis.

Authors:  Edwina A Brown; Martin Wilkie
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-27       Impact factor: 8.237

2.  No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.

Authors:  Gang Jee Ko; Yoshitsugu Obi; Melissa Soohoo; Tae Ik Chang; Soo Jeong Choi; Csaba P Kovesdy; Elani Streja; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2018-11-13       Impact factor: 3.754

Review 3.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

4.  Living with frailty and haemodialysis: a qualitative study.

Authors:  Hannah M L Young; Nicki Ruddock; Mary Harrison; Samantha Goodliffe; Courtney J Lightfoot; Juliette Mayes; Andrew C Nixon; Sharlene A Greenwood; Simon Conroy; Sally J Singh; James O Burton; Alice C Smith; Helen Eborall
Journal:  BMC Nephrol       Date:  2022-07-22       Impact factor: 2.585

5.  Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults.

Authors:  Sabine N van der Veer; Wim van Biesen; Pascale Bernaert; Davide Bolignano; Edwina A Brown; Adrian Covic; Ken Farrington; Kitty J Jager; Jeroen Kooman; Juan F Macías-Núñez; Andrew Mooney; Barbara C van Munster; Eva Topinkova; Nele J A Van Den Noortgate; Gerhard Wirnsberger; Jean-Pierre Michel; Ionut Nistor
Journal:  Int Urol Nephrol       Date:  2016-03-17       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.